Similar articles

• Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).

  Lloyd SJ, Josimovich JB, Archer DF. Lloyd SJ, et al. Am J Obstet Gynecol. 1975 May 1;122(1):85-9. doi: 10.1016/0002-9378(75)90618-3. Am J Obstet Gynecol. 1975. PMID: 1168997
• Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.

  Seki K, Seki M, Okumura T. Seki K, et al. Acta Endocrinol (Copenh). 1975 May;79(1):25-33. doi: 10.1530/acta.0.0790025. Acta Endocrinol (Copenh). 1975. PMID: 1173307
• Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.

  Dickey RP, Stone SC. Dickey RP, et al. Obstet Gynecol. 1976 Jul;48(1):84-9. Obstet Gynecol. 1976. PMID: 934580
• Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

  Besser GM, Parke L, Edwards CR, Forsyth IA, McNeilly AS. Besser GM, et al. Br Med J. 1972 Sep 16;3(5828):669-72. doi: 10.1136/bmj.3.5828.669. Br Med J. 1972. PMID: 4675488 Free PMC article.
• Galactorrhoea.

  Besser GM, Edwards CR. Besser GM, et al. Br Med J. 1972 Apr 29;2(5808):280-2. doi: 10.1136/bmj.2.5808.280. Br Med J. 1972. PMID: 4553815 Free PMC article. Review. No abstract available.